Wildtype Kras2 can inhibit lung carcinogenesis in mice

Nature Genetics

Volumn 29, Issue 1, 2001, Pages 25-33

  Zhang, Zhongqiu ^a   Wang, Yian ^a   Vikis, Haris G ^b   Johnson, Leisa ^c   Liu, Gongjie ^a   Li, Jie ^a   Anderson, Marshall W ^d   Sills, Robert C ^e   Hong, H L ^e   Devereux, Theodora R ^e   Jacks, Tyler ^c   Guan, Kun Liang ^b   You, Ming ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG CARCINOGENESIS; LUNG TUMOR; MOUSE; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 17944369909     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng721     Document Type: Article

References (50)

1. Role of proto-oncogene activation in carcinogenesis
2. Ras genes
3. How does p21ras transform cells?
4. Dominant transformation by mutated human ras genes in vitro requires more than 100 times higher expression than is observed in cancers
5. Activation of the K-ras protooncogenes in spontaneously occurring and chemically induced lung tumors of the strain a mouse
6. A molecular approach to leukemogenesis: Mouse lymphomas contain an activated c-ras oncogene
7. Malignant transformation of early passage rodent cells by a single mutated human oncogene
8. Spontaneous or carcinogen-mediated amplification of a mutated ras gene promotes neoplastic transformation
9. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene
10. Predisposition to neoplastic transformation caused by gene replacement of H-ras1
11. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation
12. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7
13. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7
14. The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation
15. Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y
16. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
17. K-ras is an essential gene in the mouse with partial functional overlap with N-ras
18. Lung tumors in mice: Application to carcinogenesis bioassay
19. Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines
20. Linkage disequilibrium and physical mapping of Pas1 in mice
21. High frequency of codon 61 K-ras A →T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene
22. Function and regulation of Ras
23. Activators and effectors of Ras p21 proteins
24. Frequent loss of heterozygosity in region of the k1p1 locus in non-small cell lung cancer: Evidence for a new tumor suppressor gene on the short arm of chromosome 12
25. Prognostic value of loss of heterozygosity and K-Ras mutations in lung adenocarcinoma
26. Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
27. ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons
28. Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons
29. Neurotrophin signalling
30. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor
31. Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line
32. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
33. Activated N-ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells
34. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP
35. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus
36. ras gene amplification and malignant transformation
37. Recombinant BALB and Harvey sarcoma viruses with normal proto-ras-coding regions transform embryo cells in culture and cause tumors in mice
38. Differential expression of the normal and mutated Kras alleles in chemically induced thymic lymphomas
39. The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility
40. A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells
41. c-Ki-ras amplification in human lung cancer
42. Amplification of protooncogenes in surgical specimens of human lung carcinomas
43. Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer
44. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis
45. Gene amplification and tumor progression
46. The clinicopathological significance of K-ras point mutation and gene amplification in endometrial cancer
47. Oncogene amplification in squamous cell carcinoma of the oral cavity
48. Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells
49. National Toxicology Program Toxicology and carcinogenesis studies of chloroprene (CAS no. 126-99-8) in F344/N rats and B6C3F1 mice (inhalation studies)
50. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase